Last reviewed · How we verify
Medox® Anthocyanin capsules
Anthocyanins exert antioxidant and anti-inflammatory effects by scavenging free radicals and modulating inflammatory pathways.
Anthocyanins exert antioxidant and anti-inflammatory effects by scavenging free radicals and modulating inflammatory pathways. Used for Phase 3 indication not publicly specified; likely cardiovascular or metabolic disease based on anthocyanin research.
At a glance
| Generic name | Medox® Anthocyanin capsules |
|---|---|
| Also known as | Medox® Placebo capsules |
| Sponsor | Sun Yat-sen University |
| Drug class | Botanical/Nutraceutical antioxidant |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular, Metabolic, or General wellness (specific indication unclear) |
| Phase | Phase 3 |
Mechanism of action
Anthocyanins are polyphenolic compounds that act as potent antioxidants, neutralizing reactive oxygen species and reducing oxidative stress. They also inhibit pro-inflammatory cytokine production and modulate signaling pathways involved in inflammation, potentially providing cytoprotective benefits across multiple organ systems.
Approved indications
- Phase 3 indication not publicly specified; likely cardiovascular or metabolic disease based on anthocyanin research
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medox® Anthocyanin capsules CI brief — competitive landscape report
- Medox® Anthocyanin capsules updates RSS · CI watch RSS
- Sun Yat-sen University portfolio CI